The National Cancer Institute (NCI) has selected two assays to be included in the Vanguard Study: Avantect® Multi-Cancer Detection Test by ClearNote Health and Shield™ Multi-Cancer Detection Test by Guardant Health.
POSTED: 1/7/2025
SOURCE: DCP News